Individual donor assessment in the United States: Impact on deferral and infectious disease marker rates

Documenti analoghi

• Possible NAT ‐negative transfusion‐transmitted Babesia microti
  di: Courtney Hopkins, et al.
  Pubblicazione: (2025)
• Blood donor return behavior in South Africa and the United States before and during the COVID‐19 pandemic
  di: Huzbah Jagirdar, et al.
  Pubblicazione: (2024)
• Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use
  di: Franke A. Quee, et al.
  Pubblicazione: (2024)
• Factors associated with HIV infection in U.S. blood donors across evolving deferral policies
  di: Vivian I. Avelino‐Silva, et al.
  Pubblicazione: (2025)
• HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment
  di: Eduard Grebe, et al.
  Pubblicazione: (2025)